Patents by Inventor Katrien Van Beneden

Katrien Van Beneden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11008393
    Abstract: Methods are provided for the treatment of IL-6R related diseases. More specifically, specific dose regimens and pre-filled syringes are provided for subcutaneous administration, to subjects suffering an IL-6R related disease, of immunoglobulin single variable domains that bind IL-6R.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: May 18, 2021
    Assignee: Ablynx N.V.
    Inventors: Sven Hoefman, Maria-Laura Sargentini-Maier, Katrien Van Beneden
  • Publication number: 20190119392
    Abstract: Methods are provided for the treatment of IL-6R related diseases. More specifically, specific dose regimens and pre-filled syringes are provided for subcutaneous administration, to subjects suffering an IL-6R related disease, of immunoglobulin single variable domains that bind IL-6R.
    Type: Application
    Filed: September 27, 2018
    Publication date: April 25, 2019
    Applicant: Ablynx N.V.
    Inventors: Sven Hoefman, Maria-Laura Sargentini-Maier, Katrien Van Beneden
  • Patent number: 10118967
    Abstract: Methods are provided for the treatment of IL-6R related diseases. More specifically, specific dose regimens and pre-filled syringes are provided for subcutaneous administration, to subjects suffering an IL-6R related disease, of immunoglobulin single variable domains that bind IL-6R.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: November 6, 2018
    Assignee: Ablynx N.V.
    Inventors: Sven Hoefman, Maria Laura Sargentini-Maier, Katrien Van Beneden
  • Publication number: 20160326252
    Abstract: Methods are provided for the treatment of IL-6R related diseases. More specifically, specific dose regimens and pre-filled syringes are provided for subcutaneous administration, to subjects suffering an IL-6R related disease, of immunoglobulin single variable domains that bind IL-6R.
    Type: Application
    Filed: October 21, 2015
    Publication date: November 10, 2016
    Applicant: ABLYNX NV
    Inventors: Sven Hoefman, Maria Laura Sargentini-Maier, Katrien Van Beneden
  • Publication number: 20030095965
    Abstract: The present invention relates to monoclonal antibodies to the Ly49E and Ly49C receptors and to monoclonal antibodies to the CD94/NKG2A, CD94/NKG2C and/or CD94/NKG2E receptors, and to uses thereof in preventing, alleviating and/or treating diseases associated with transplantation (organ/bone marrow) or with autoimmunity.
    Type: Application
    Filed: May 2, 2002
    Publication date: May 22, 2003
    Inventors: Katrien Van Beneden, Jozef De Boever, Georges Leclercq